Anastasia Stergioti

Anastasia Stergioti

Auto-generated profile, based on publicly available information

Anastasia Stergioti

Diabetes Center, First Department of Propaedeutic Internal Medicine, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2025 in The International Journal of Lower Extremity Wounds
Verified
Journal Article
Closed access
ASAnastasia Stergioti
Anastasia Stergioti
KMKonstantinos Manganas
Konstantinos Manganas
ETEvangelia Tzeravini
Evangelia Tzeravini
OKOurania Kosta
Ourania Kosta
IEIoanna Eleftheriadou
Ioanna Eleftheriadou
ATAnastasios Tentolouris
Anastasios Tentolouris
Charcot neuro-osteoarthropathy (CN) is a severe and often underrecognized complication of diabetes mellitus, primarily affecting individuals with diabetic neuropathy. Its clinical course is marked by progressive joint destruction and foot deformities. This review aims to summarize current evidence regarding the role of CN in the development and recurrence of diabetic foot ulcers (DFUs), the risk of amputation, and long-term survival outcomes, as well as to highlight key mechanisms contributing to these complications. Individuals with CN exhibit a significantly higher risk of DFUs, particularly in the midfoot region, due to structural deformities and increased plantar pressure. The risk of amputation is markedly elevated in individuals with CN, especially when DFUs are present. Mortality rates in CN are substantial, with five-year survival comparable to or worse than several malignancies. The development of foot ulcers and amputations in CN results from a complex interaction of neuropathy, structural deformity and chronic inflammation. Therefore, CN is a high-risk condition associated with serious foot complications and elevated mortality. Early recognition, multidisciplinary management, and further research into its independent prognostic impact are essential to improve long-term outcomes.

11 June 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
MPMaria Patsiliva
Maria Patsiliva
ATAikaterini Theodorakopoulou
Aikaterini Theodorakopoulou
ASAnastasia Stergioti
Anastasia Stergioti
Eleni RebelosEleni Rebelos
Eleni Rebelos
Evangelos LiberopoulosEvangelos Liberopoulos
Evangelos Liberopoulos
NTNikolaos Tentolouris
Nikolaos Tentolouris
Background/Objectives: Advanced glycation end-products (AGEs) are implicated in the vascular complications of type 2 diabetes mellitus (T2DM). Although the Mediterranean diet (MD) confers well-recognized benefits, adherence among people with T2DM is moderate. Evidence regarding the relationship between adherence to the MD and AGEs remains limited. This study aimed to investigate the association between adherence to the MD and AGE levels in individuals with T2DM in Greece. Methods: Adults with T2DM were enrolled in this cross-sectional study. Ocular and skin AGEs were assessed using autofluorescence techniques, while serum AGEs were quantified using an enzyme-linked immunosorbent assay (ELISA). MD adherence was scored with the Mediterranean Diet Score (MedDietScore) (range 0–55). Results: Sixty-one individuals were studied (mean age: 65 ± 9 years; 35 men). Median glycated hemoglobin (HbA1c) and MedDietScore were 6.95 (6.2–7.5)% and 29.0 (27.5–31.5), respectively. Higher adherence to the MD was more frequent among women (p = 0.019) and was associated with lower HbA1c levels (p = 0.002). MedDietScore was inversely correlated with HbA1c (ρ = −0.437, p < 0.001), ocular AGEs (ρ = −0.435, p = 0.013), and skin AGEs (ρ = −0.309, p = 0.033). In multivariable regression analyses, higher adherence to the MD was independently associated with lower ocular (p = 0.043) and skin AGEs (p = 0.005). Conclusions: Higher adherence to the MD was associated with female sex and lower HbA1c. MedDietScore was inversely related to skin, and ocular AGE levels in individuals with T2DM.

29 April 2025 in The International Journal of Lower Extremity Wounds
Verified
Journal Article
Closed access
ASAnastasia Stergioti
Anastasia Stergioti
VKVassiliki Karra
Vassiliki Karra
MCMaria Chatzopoulou
Maria Chatzopoulou
MKMaria Kalafati
Maria Kalafati
Insulin regulates numerous metabolic functions and plays a pivotal role in the regulation of cellular growth. This scoping review was conducted due to insufficient evidence regarding the effects of topical insulin administration on ulcer-wound healing in adults, both with and without Diabetes Mellitus (DM). The main objective of this review was to investigate whether the local application of insulin to ulcers-wounds could be used safely to promote faster healing of ulcers. We conducted a comprehensive search of PubMed, Cochrane, and EBSCO databases for primary studies, with no date restrictions. Clinical trials, both randomized and non-randomized, involving adults (> 19 years) with wounds-ulcers, regardless of DM status, were included. A total number of 173 articles were initially identified. Following the application of the PICOS criteria, 14 articles were included in the study. The analysis revealed that topical insulin, via injection or dressing, accelerates ulcer healing, indicating its role beyond blood glucose regulation. The majority of studies reported better wound size reduction and closure with insulin than alternative treatments, with local injection being most effective. In most cases, applying insulin to wounds did not cause adverse effects. The review concluded that insulin may be a valuable addition to standard ulcer care treatments.